To explore the clinical relevance of stromal AR action as a tumor niche, we compared GSEA based on DEGs of basal versus luminal cell in human prostate tumors with those in our mouse models, and identified similar enriched signaling pathways between human samples and HiMyc mice. The gene discussed is AR; the disease is neoplasm.